Oneness Competitors

Stocks . Taiwan . 
Stock . Oneness Biotech Co
4743 Stock  TWD 105.00  2.00  1.87%   
Oneness Biotech competes with Symtek Automation, WiseChip Semiconductor, Novatek Microelectronics, Leader Electronics, and Information Technology; as well as few others. The company operates under Healthcare sector and is part of Biotechnology industry. Analyzing Oneness Biotech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Oneness Biotech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Oneness Biotech Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Oneness Biotech competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
102.56105.00107.44
Details
Intrinsic
Valuation
LowRealHigh
95.2197.65115.50
Details
Naive
Forecast
LowNextHigh
109.43111.87114.31
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
103.54114.52125.50
Details

Oneness Biotech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Oneness Biotech and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Oneness and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Oneness Biotech does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
9921
+ 0.82
5245
9921
+ 0.82
3034
2882A
+ 0.76
6438
9908
+ 0.7
9921
3034
+ 0.68
5245
6209
+ 0.66
3034
  
High negative correlations   
9921
- 0.91
6438
9908
- 0.75
6438
3034
- 0.69
6438
2882A
- 0.64
9921
5245
- 0.62
6438
9908
- 0.57
2882A

Risk-Adjusted Indicators

There is a big difference between Oneness Stock performing well and Oneness Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oneness Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
6438  2.74  0.77  0.24  4.41  2.02 
(3.78)
 9.79 
(3.68)
 17.42 
5245  1.57 (0.15) 0.00 (16.11) 0.00 
 0.00 
 2.89 
(3.45)
 16.35 
3034  1.11 (0.22) 0.00 (0.73) 0.00 
 0.00 
 1.97 
(2.55)
 8.21 
3058  1.71  0.03  0.00  0.04  0.00 
 0.00 
 2.98 
(2.89)
 15.92 
6697  1.23 (0.01)(0.04) 0.08  1.71 
(1.49)
 2.33 
(2.68)
 15.29 
6209  1.08 (0.18) 0.00 (0.53) 0.00 
 0.00 
 1.98 
(2.38)
 5.38 
9921  1.66 (0.70) 0.00 (2.69) 0.00 
 0.00 
 1.99 
(5.13)
 14.43 
2395  1.16 (0.08)(0.06)(0.01) 1.76 
(1.32)
 2.71 
(2.04)
 7.98 
2882A  0.09  0.00 (0.55) 0.24  0.00 
(0.26)
 0.33 
(0.16)
 0.82 
9908  0.19 (0.05) 0.00 (0.74) 0.00 
 0.00 
 0.33 
(0.49)
 1.16 
All Fundamental Data

Oneness Biotech Competitive Analysis

The better you understand Oneness Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Oneness Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Oneness Biotech's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
4743 6438 5245 3034 3058 6697 6209 9921 2395 2882A
 1.87 
 105.00 
Oneness
 2.83 
 206.00 
Symtek
 0.60 
 33.05 
WiseChip
 0.10 
 484.50 
Novatek
 0.92 
 16.45 
Leader
 0.45 
 44.80 
Information
 1.43 
 24.80 
Kinko
 1.32 
 150.00 
Giant
 3.43 
 347.00 
Advantech
 0.16 
 61.00 
Cathay
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Solid
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Very Weak
Modest
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Low
Low
Low
Low
Low
Low
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Hold
Strong Sell
Cautious Hold
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Hold
Strong Sell
Current Ratio
N/A
1.49
1.29
2.06
1.25
N/A
2.32
1.42
2.14
1.19
Net Asset
15.73 B
6.18 B
1.71 B
120.59 B
5.24 B
N/A
4.62 B
77.2 B
57.83 B
11.59 T
Profit Margin
1.06
0.13
0.15
0.25
-0.0544
N/A
0.0174
0.0741
0.16
0.13
EBITDA
(193.72 M)
904.7 M
368.53 M
49.24 B
(114.34 M)
N/A
135.66 M
10.89 B
11.37 B
(235.56 B)
Operating Margin
-0.16
0.16
0.17
0.3
-0.042
N/A
-0.0298
0.0928
0.18
-0.42
Current Valuation
92.26 B
5.77 B
2.5 B
144.82 B
2.91 B
N/A
4.78 B
115.88 B
255.56 B
(1.21 T)
Price To Book
6.54
1.78
2.08
3.05
1.11
N/A
1.43
3.14
6.42
N/A
Five Year Return
N/A
4.68
4.56
6.09
N/A
N/A
N/A
2.82
2.55
N/A
Retained Earnings
N/A
N/A
N/A
20.21 B
289 M
N/A
1.33 B
14.97 B
10.04 B
N/A
Current Asset
N/A
N/A
N/A
34.22 B
2.77 B
N/A
2.91 B
34.81 B
20.14 B
N/A
Beta
1.65
1.16
0.94
1.12
0.92
N/A
1.4
1.14
0.73
0.61
Number Of Employees
20
N/A
275
30
29
N/A
11
39
30
57.1 K
Shares Outstanding
387.86 M
71.43 M
43.16 M
608.51 M
156.58 M
N/A
174.23 M
409.06 M
777.84 M
12.5 B
Cash Flow From Operations
(288.89 M)
678.36 M
325.69 M
41.72 B
(112.27 M)
N/A
(247.69 M)
(4.96 B)
9.13 B
72.52 B
Annual Yield
N/A
0.0651
0.0857
0.14
0.0133
N/A
0.0198
0.0481
0.0219
0.0404
Total Debt
N/A
76.21 M
31.69 M
293.66 M
156.45 M
N/A
548.27 M
3.16 B
1.07 B
429.04 B
Return On Equity
0.0788
0.22
0.19
0.42
-0.17
N/A
0.0206
0.23
0.27
0.12
Z Score
N/A
54.0
42.6
N/A
6.0
N/A
4.8
16.6
N/A
0.6
Return On Asset
-0.0068
0.0797
0.0872
0.26
-0.0248
N/A
-0.0148
0.0647
0.13
-0.0129
Book Value Per Share
39.63
49.64
27.7
100.74
9.27
N/A
18.53
80.43
52.92
21.23
Current Liabilities
N/A
N/A
N/A
10.2 B
2.13 B
N/A
1.42 B
23.12 B
13.17 B
N/A
Total Asset
15.73 B
6.18 B
1.71 B
120.59 B
5.24 B
N/A
4.62 B
77.2 B
57.83 B
11.59 T
Debt To Equity
N/A
0.31
0.17
1.0
57.3
N/A
17.9
71.3
3.3
0.5
Last Dividend Paid
N/A
6.3
4.48
N/A
N/A
N/A
N/A
10.0
8.0
3.5
Target Price
N/A
N/A
N/A
371.06
N/A
N/A
39.43
252.22
340.36
N/A
Shares Owned By Institutions
14.8
2.13
0.43
40.9
0.96
N/A
1.38
27.91
26.61
0.01
Market Capitalization
105.11 B
6.89 B
2.27 B
242.49 B
1.57 B
N/A
4.5 B
84.47 B
287.02 B
471.73 B
Price To Earning
N/A
13.75
17.43
13.01
0.68
N/A
442.19
24.07
28.54
7.79
Price To Earnings To Growth
N/A
N/A
N/A
2.12
N/A
N/A
N/A
4.48
1.5
N/A
Price To Sales
88.17
1.14
1.64
1.54
0.34
N/A
1.2
0.95
3.89
0.82
Net Income
(403.3 M)
651.65 M
197.86 M
38.87 B
(321.88 M)
N/A
(150.46 M)
5.93 B
8.25 B
139.51 B
Earnings Per Share
2.79
10.29
5.1
57.16
-2.42
N/A
0.39
17.48
13.37
8.58
Shares Owned By Insiders
30.64
20.98
51.48
5.1
17.93
N/A
23.7
20.18
48.01
N/A
Revenue
65.77 M
4.91 B
1.45 B
135.37 B
4.72 B
N/A
3.61 B
81.84 B
58.62 B
621.86 B
Working Capital
N/A
N/A
N/A
24.02 B
644 M
N/A
1.49 B
11.69 B
6.97 B
N/A
Cash And Equivalents
N/A
1.41 B
139.05 M
20.45 B
810.93 M
N/A
992.72 M
10.86 B
9.3 B
2.3 T
Cash Per Share
N/A
23.02
3.08
33.6
4.94
N/A
6.09
28.94
13.31
174.87
Gross Profit
45.04 M
1.6 B
505.36 M
50.94 B
358.69 M
N/A
201.58 M
19.76 B
22.13 B
325.74 B
Day Typical Price
105.67
209.67
32.98
485.5
16.5
44.87
24.77
151.33
345.5
61.03
Accumulation Distribution
0.0279
0.0507
0.0387
0.0062
0.021
0.0133
0.012
0.026
0.0412
0.0016
Market Facilitation Index
3.0
11.0
1.3
3.0
0.35
0.6
0.3
4.0
14.5
0.1
Daily Balance Of Power
(0.67)
(0.55)
(0.15)
0.1667
0.4286
0.3333
1.166667
(0.50)
0.7931
(1.00)
Period Momentum Indicator
(2.00)
(6.00)
(0.20)
0.5
0.15
0.2
0.35
(2.00)
11.5
(0.10)
Rate Of Daily Change
0.98
0.97
0.99
1.0
1.01
1.0
1.01
0.99
1.03
1.0
Day Median Price
106.0
211.5
32.95
486.0
16.52
44.9
24.75
152.0
344.75
61.05
Price Action Indicator
(2.00)
(8.50)
N/A
(1.25)
N/A
N/A
0.23
(3.00)
8.0
(0.10)
Coefficient Of Variation
(421.87)
459.18
(1,892)
(822.23)
(52,238)
5484.69
(1,002)
(343.50)
158132.94
822.88
Mean Deviation
1.87
2.74
1.57
1.11
1.71
1.23
1.08
1.66
1.16
0.0885
Jensen Alpha
(0.69)
0.7697
(0.15)
(0.22)
0.025
(0.01)
(0.18)
(0.70)
(0.08)
0.0039
Total Risk Alpha
(0.97)
0.2406
(0.53)
(0.42)
(0.40)
(0.28)
(0.35)
(1.02)
(0.26)
(0.01)
Sortino Ratio
N/A
0.2448
N/A
N/A
N/A
(0.04)
N/A
N/A
(0.06)
(0.55)
Downside Variance
N/A
7.62
N/A
N/A
N/A
4.06
N/A
N/A
4.15
0.0377
Standard Deviation
2.48
3.67
2.59
1.51
2.56
2.06
1.36
2.28
1.68
0.1448
Kurtosis
0.9253
0.9579
6.24
2.39
5.51
8.34
(0.06)
2.25
4.13
3.01
Potential Upside
3.45
9.79
2.89
1.97
2.98
2.33
1.98
1.99
2.71
0.33
Treynor Ratio
(0.76)
4.41
(16.11)
(0.73)
0.0427
0.0826
(0.53)
(2.69)
(0.01)
0.238
Maximum Drawdown
13.76
17.42
16.35
8.21
15.92
15.29
5.38
14.43
7.98
0.8224
Variance
6.13
13.5
6.68
2.27
6.55
4.23
1.86
5.21
2.83
0.021
Market Risk Adjusted Performance
(0.75)
4.42
(16.10)
(0.72)
0.0527
0.0926
(0.52)
(2.68)
(0)
0.248
Risk Adjusted Performance
(0.17)
0.1743
(0.03)
(0.09)
0.0056
0.0202
(0.07)
(0.22)
0.0059
0.0501
Skewness
0.1526
0.9501
1.42
(0.88)
1.58
1.34
(0.31)
(0.40)
(1.17)
1.2
Semi Deviation
N/A
2.02
N/A
N/A
N/A
1.71
N/A
N/A
1.76
0.0
Information Ratio
(0.29)
0.184
(0.10)
(0.20)
(0.05)
(0.04)
(0.19)
(0.35)
(0.07)
(0.74)
Value At Risk
(4.76)
(3.68)
(3.45)
(2.55)
(2.89)
(2.68)
(2.38)
(5.13)
(2.04)
(0.16)
Expected Short fall
N/A
(3.78)
N/A
N/A
N/A
(1.49)
N/A
N/A
(1.32)
(0.26)
Downside Deviation
N/A
2.76
N/A
N/A
N/A
2.02
N/A
N/A
2.04
0.1942
Semi Variance
N/A
4.1
N/A
N/A
N/A
2.93
N/A
N/A
3.11
(0.01)

Oneness Biotech Competition Performance Charts

Five steps to successful analysis of Oneness Biotech Competition

Oneness Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Oneness Biotech in relation to its competition. Oneness Biotech's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Oneness Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Oneness Biotech's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Oneness Biotech, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Oneness Biotech position

In addition to having Oneness Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cryptocurrency ETFs Thematic Idea Now

Cryptocurrency ETFs
Cryptocurrency ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Cryptocurrency ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Oneness Stock Analysis

When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY